Cabotegravir

(3S,11aR)-N-[(2,4-difluorophenyl)methyl]-2,3,5,7,11,11a-hexahydro-6-hydroxy-3-methyl-5,7-dioxo-oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamide

Purity / Analysis Method	>98.0% (HPLC)
Molecular Formula / Molecular Weight	C19H17F2N3O5 = 405.35
CAS RN	1051375-10-0

Unit	Price
100 mg	7500
250 mg	11750
1 g	17500

Description
Additional information

Appearance	Solid
Purity(HPLC)	min. 98.0 area%

Note	• Pharmaceutical Ingredients (for Research and Experimental Use) is provided as delivered and specified by the issuing Pharmacopoeia. • The contents of the specifications are subject to change without advance notice. The specification values displayed here are the most up to date values. There may be cases where the product labels display different specification; however, the product quality still meets the latest specification.

Note

• Pharmaceutical Ingredients (for Research and Experimental Use) is provided as delivered and specified by the issuing Pharmacopoeia.
• The contents of the specifications are subject to change without advance notice. The specification values displayed here are the most up to date values. There may be cases where the product labels display different specification; however, the product quality still meets the latest specification.

Researching Relationships

Cabotegravir

For API and Polymers

Useful Links

Important Links

Location

Cabotegravir

Related products

Aminophylline

Acetazolamide

Alendronate Sodium (Alendronic Acid Mono)

Abacavir sulfate

For API and Polymers

Useful Links

Important Links

Location